Rani Therapeutics Inc. (RANI)
1.31
0.03 (2.34%)
At close: Jan 15, 2025, 3:59 PM
1.31
-0.38%
After-hours Jan 15, 2025, 04:00 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| PE Ratio | -2.49 | -2.22 | -6.07 | -13 | -8.16 |
| PS Ratio | n/a | n/a | 118.62 | 469.97 | 221.78 |
| PB Ratio | 6.58 | 3.81 | 6.80 | -1.92 | -2.25 |
| P/FCF Ratio | -1.61 | -2.92 | -9.84 | -13.44 | -7.8 |
| P/OCF Ratio | -1.65 | -3.02 | -10 | -14.51 | -8.27 |
| OCF/S Ratio | n/a | n/a | -11.87 | -32.38 | -26.83 |
| Debt / Equity Ratio | 2.34 | 0.82 | n/a | -0.03 | -1.2 |
| Quick Ratio | 6.36 | 20.96 | 45.30 | 14.12 | 4.84 |
| Current Ratio | 6.36 | 20.96 | 45.30 | 14.12 | 4.84 |
| Asset Turnover | n/a | n/a | 0.02 | 0.01 | 0.04 |
| Interest Coverage | -13 | -59.24 | -110.73 | -133.42 | -2.71K |
| Return on Equity (ROE) | -2.64 | -1.72 | -1.12 | 0.15 | 0.28 |
| Return on Assets (ROA) | -0.59 | -0.59 | -0.43 | -0.21 | -1.16 |
| Return on Capital (ROIC) | -1.32 | -0.61 | -0.42 | -0.22 | -1.39 |
| Dividend Yield | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | 100.00% | 100.00% | 100.00% |
| Net Profit Margin | n/a | n/a | -1.95K% | -3.62K% | -2.72K% |
| Pretax Profit Margin | n/a | n/a | -1.95K% | -3.61K% | -2.72K% |
| Operating Profit Margin | n/a | n/a | -1.90K% | -3.58K% | -2.76K% |
| FCF Margin | n/a | n/a | -1.21K% | -3.50K% | -2.84K% |
| EBITDA Margin | n/a | n/a | -1.92K% | -3.45K% | -2.66K% |